Related Experiment Videos
Fosphenytoin use in children
1Division of Child Neurology, Medical College of Virginia/Virginia Commonwealth University, Richmond 23298, USA.
Neurology
|June 1, 1996
Summary
Fosphenytoin offers a safer and more flexible alternative to phenytoin for seizure management in children. This prodrug can be administered intramuscularly and intravenously, overcoming limitations of traditional phenytoin therapy.
Area of Science:
- Pediatric Neurology
- Clinical Pharmacology
Background:
- Phenytoin is a common treatment for acute seizures in children, but its administration has limitations.
- Intramuscular (i.m.) administration of phenytoin is not possible.
- Intravenous (i.v.) phenytoin administration can be challenging in newborns and critically ill infants due to venous access issues.
Purpose of the Study:
- To evaluate the safety and efficacy of fosphenytoin, a phenytoin prodrug, in pediatric populations.
- To compare fosphenytoin administration routes (i.v. and i.m.) with phenytoin.
- To investigate the pharmacokinetic profile of fosphenytoin in children and young adults.
Main Methods:
- Clinical studies involving i.v. and i.m. fosphenytoin administration.
- Assessment of efficacy, safety, and pharmacokinetics.
- Comparison between pediatric patients (5-18 years) and young adults.
Main Results:
- Fosphenytoin can be safely administered via the i.m. route.
- Fosphenytoin offers advantages for i.v. administration compared to phenytoin.
- Efficacy, safety, and pharmacokinetics of fosphenytoin were found to be similar in children (5-18 years) and young adults.
Conclusions:
- Fosphenytoin presents a viable alternative to phenytoin for pediatric seizure treatment, offering improved administration options.
- Further research is ongoing to determine the safety and pharmacokinetic profile of fosphenytoin in younger children and infants.